Home/Filings/4/0000950170-25-105132
4//SEC Filing

Warner Douglas J 4

Accession 0000950170-25-105132

CIK 0001863127other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 4:38 PM ET

Size

5.3 KB

Accession

0000950170-25-105132

Insider Transaction Report

Form 4
Period: 2025-08-07
Warner Douglas J
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-08-07+200,000200,000 total
    Exercise: $10.75Exp: 2035-08-06Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on August 7, 2026, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

1 file

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001941311

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:38 PM ET
Size
5.3 KB